Home › Funds › ADAR1 Capital Management, LLC › REGN

ADAR1 Capital Management, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

ADAR1 Capital Management, LLC reported holding 22,208 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$13.8M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. ADAR1 Capital Management, LLC has disclosed REGN holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)22.21K sh
Reported value held$13.85M
Portfolio Weight0.77%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's REGN position evolved

ADAR1 Capital Management, LLC first disclosed a stake in REGN in Q1 2024 at 2,300 shares (US$2.2M). The position peaked in Q2 2026 at 22,208 shares, worth US$13.8M. Across 9 filings, ADAR1 Capital Management, LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 22,208 shares valued at US$13.8M — an increase of 10,054 shares quarter over quarter.. Notable position changes include a 147% increase in Q2 2025 (shares rose 8% over the following quarter), a 367% increase in Q3 2025 (shares rose 36% over the following quarter), a 83% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.30K $2.21M New
Q3 2024 871 $915.63K New
Q4 2024 1.36K $969.48K Add
Q1 2025 1.36K $863.19K Hold
Q2 2025 3.36K $1.76M Add
Q3 2025 15.70K $8.83M Add
Q4 2025 12.05K $9.30M Reduce
Q1 2026 12.15K $9.39M Add
Q2 2026 22.21K $13.85M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held REGN?

ADAR1 Capital Management, LLC has disclosed REGN holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

What is ADAR1 Capital Management, LLC's current position in REGN?

As of Q2 2026, ADAR1 Capital Management, LLC holds 22.21K shares of REGN (REGENERON PHARMACEUTICALS), valued at $13.85M, representing 0.77% of its reported portfolio and ranking #35.

Has ADAR1 Capital Management, LLC been buying or selling REGN?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in REGN. The position peaked in Q2 2026 at 22.21K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.